Uncategorized

Nothing Conclusive

In the January 2024 edition of JAMA Ophthalmology, Dr. Paul McCann and colleagues wrote a review article about dry eye treatment. They stated, “among reliable systemic reviews, no conclusive evidence was identified for any dry eye intervention.” What?! We can’t prove that we can do anything about dry eye? So we might as well do…

Read More

Tepezza and Hearing

In the January 2024 issue of the journal Ophthalmology, Dr. Jamie Keen and colleagues published a study highlighting a side effect of the medication Tepezza. Tepezza is advertised on TV for thyroid eye disease. One of the adverse effects of the medication is that it can adversely affect hearing function. The article warns that it…

Read More

Grease it up!

I venture that it is intuitively obvious that an ointment would be a better lubricant than a watery liquid, but perhaps it is not. Often, I tell my patients that the best thing that they can do if they have a tear film problem, which I argue that most patients do, is lubricate their eye…

Read More

More eye disease

In the December 2023 edition of the journal Ophthalmology, Dr. Joshua Ehrlich and colleagues published a study that showed that the prevalence of eye disease is increasing. They studied Medicare beneficiaries 68 years old and older. Among other findings, they found that the prevalence of macular degeneration increased from 6.8% in 2005 to 9.4% in…

Read More

Insulin Eye Drops?!

In the November 2023 edition of the journal Cornea, Dr. Aina Malindri Dasrilsyah and colleagues published a study that showed that insulin eye drops are helpful for healing corneal scratches. They compared topical insulin with artificial tears in patients with diabetes. The scratches of the cornea were created during eye surgery (to help with retina…

Read More

MRSA

In a recent post on an ophthalmology forum, one doctor made an important clarification about patients having eye surgery. The post had to with a type of bacteria–methicillin-resistant Staph aureus (MRSA). If a patient has an active infection, especially of the face, with MRSA, we may strongly consider cancelling cataract surgery. Usually, we can reschedule…

Read More

Reuse!

In the November 2023 edition of the Journal of Cataract & Refractive Surgery, Lydia Lam and colleagues published a paper that shows that there is significant waste associated with betadine use in the ophthalmic operating room. Betadine is used as an antiseptic during many surgeries, including eye surgeries. The authors of this study found quite…

Read More

Lotilaner

In the October 2023 edition of the Journal Ophthalmology, Dr. Ian Gaddie and colleagues published a study about lotilaner. Lotilaner is a medication that fights Demodex mites. Mites!?! Yes, some people can get mites that live in their eyelashes and cause inflammation. Lotilaner treatment for 6 weeks decreased a lot of the symptoms and killed…

Read More

Lighting It Up

In the October 2023 edition of the Journal of Cataract and Refractive Surgery, Dr. Youngsub Eom and colleagues showed that patients preferred illumination from the inside of the eye rather than the outside. Conventional eye surgery often relies on a microscope with bright lights shining down on the patient’s eyeball. These bright lights certainly can…

Read More

Changing Corneal Sensitivity

In the October 2023 edition of the journal Cornea, Dr. Daniela Nosch and colleagues published a study that showed that corneal sensitivity may decrease with increasing age. I think that this has long been suspected from a clinical perspective. However, the authors warn, and I agree, that this should not be taken to mean that…

Read More